Want to see RADX full AI Analyst Report?
Radiopharm Theranostics Limited Sponsored ADR (RADX) Q2 2026 Earnings Report
RADX Q2 2026 EPS Results
- Actual EPS
- -$2.11
- Consensus EPS
- -$2.10
- Beat/Miss
- Missed by -$0.01
- One Year Ago EPS
- -$1.94
RADX Q2 2026 Revenue Results
- Actual Revenue
- $907.90K
- Expected Revenue
- $0
- Beat/Miss
- Beat by +$907.90K
- YoY Revenue Growth
- -0.73%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 02/27/2026
- Time
- Before Open
- Conference Call
- Friday, February 27, 2026
RADX Upcoming Earnings
Radiopharm Theranostics Limited Sponsored ADR's next earnings date is estimated for February 26, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
RADX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 26, 2027 | 2027 (Q2) | -1.05- | -2.11 | ― | ― |
| Aug 28, 2026 | 2026 (Q4) | -2.56-2.11 | -1.95 | -8.04% (-0.16) | |
| Feb 27, 2026 | 2026 (Q2) | -2.10-2.11 | -1.94 | -8.56% (-0.17) | |
| Sep 16, 2025 | 2025 (Q4) | -1.96-1.95 | -10.26 | 80.97% (+8.30) | |
| Feb 28, 2025 | 2025 (Q2) | -1.97-1.94 | -14.1 | 86.24% (+12.16) | |
| Aug 29, 2024 | 2024 (Q4) | -2.00-10.26 | -12.44 | 17.57% (+2.19) | |
| Feb 29, 2024 | 2024 (Q2) | -2.02-14.10 | -5.69 | -147.59% (-8.40) | |
| Aug 31, 2023 | 2023 (Q4) | -3.79-12.44 | -1.47 | -748.84% (-10.98) | |
| Feb 28, 2023 | 2023 (Q2) | ―-5.69 | -31.83 | 82.11% (+26.14) | |
| Sep 30, 2022 | 2022 (Q4) | ―-1.47 | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
